Johnson & Johnson JNJ shares are trading slightly higher Tuesday after the company announced better-than-expected financial results.
Johnson & Johnson said second-quarter revenue increased 3% year-over-year to $24.02 billion, which beat the estimate of $23.81 billion, according to data from Benzinga Pro. The company reported quarterly adjusted earnings of $2.59 per share, which beat the estimate of $2.57 per share.
"Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company's market leadership in the midst of macroeconomic challenges," said Joaquin Duato, CEO of Johnson & Johnson.
Johnson & Johnson cut full-year revenue guidance from a range of $94.8 billion to $95.8 billion to a range of $93.3 billion to $94.3 billion versus the estimate of $96.04 billion. The company cut full-year earnings guidance from a range of $10.15 to $10.35 per share to a range of $10 to $10.10 per share versus the estimate of $10.27 per share.
See Also: Johnson & Johnson Cuts Annual Profit Outlook, Pharma Unit Cushions Fall In Medical Devices
JNJ Price Action: Johnson & Johnson has traded between $186.69 and $155.72 over a 52-week period.
The stock was up 0.02% at $174.26 at time of publication.
Photo: BC Y from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.